- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Snapshot for Mylan Inc/PA (MYL)
| Open: | 21.7400 | Day's Range: | 21.7000 - 22.2450 | Volume: | 5,649,979 | Bid: | 21.8800 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 21.6300 | 52wk Range: | 15.4900 - 25.0000 | 1-Yr Rtn: | -6.45% | Ask: | 21.8900 |
Key Statistics for MYL
| Current P/E Ratio (ttm) | 14.7905 |
|---|---|
| Estimated P/E (12/2012) | 8.8839 |
| Earnings Per Share (USD) (ttm) | 1.4800 |
| Est. EPS (USD) (12/2012) | 2.4640 |
| Est. PEG Ratio | 0.8859 |
| Market Cap (M USD) | 9,383.07 |
| Shares Outstanding (M) | 428.65 |
| Enterprise Value (M USD) (ttm) | 14,556.19 |
| Enterprise Value/EBITDA (ttm) | 9.19 |
| Price/Book (mrq) | 2.4904 |
| Price/Sale (ttm) | 1.4947 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/27/2012 |
More MYL Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for MYL
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for MYL
Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.
| Robert J CouryChairman | Rodney L PiattVice Chairman |
| Heather BreschChief Executive Officer | Rajiv MalikPresident |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page